img

Global Dermatology OTC Medications Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dermatology OTC Medications Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Dermatology OTC Medications report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dermatology OTC Medications market is projected to reach US$ 16080 million in 2034, increasing from US$ 12780 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dermatology OTC Medications market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
External Use
Oral

Segment by Application


Hospital
Drug Store
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dermatology OTC Medications market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dermatology OTC Medications, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dermatology OTC Medications industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dermatology OTC Medications in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dermatology OTC Medications introduction, etc. Dermatology OTC Medications Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Dermatology OTC Medications market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Dermatology OTC Medications Market Overview
1.1 Dermatology OTC Medications Product Overview
1.2 Dermatology OTC Medications Market Segment by Type
1.2.1 External Use
1.2.2 Oral
1.3 Global Dermatology OTC Medications Market Size by Type
1.3.1 Global Dermatology OTC Medications Market Size Overview by Type (2018-2034)
1.3.2 Global Dermatology OTC Medications Historic Market Size Review by Type (2018-2024)
1.3.3 Global Dermatology OTC Medications Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dermatology OTC Medications Sales Breakdown by Type (2018-2024)
1.4.2 Europe Dermatology OTC Medications Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Dermatology OTC Medications Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Type (2018-2024)
2 Global Dermatology OTC Medications Market Competition by Company
2.1 Global Top Players by Dermatology OTC Medications Sales (2018-2024)
2.2 Global Top Players by Dermatology OTC Medications Revenue (2018-2024)
2.3 Global Top Players by Dermatology OTC Medications Price (2018-2024)
2.4 Global Top Manufacturers Dermatology OTC Medications Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dermatology OTC Medications Market Competitive Situation and Trends
2.5.1 Dermatology OTC Medications Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Dermatology OTC Medications Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2022)
2.7 Date of Key Manufacturers Enter into Dermatology OTC Medications Market
2.8 Key Manufacturers Dermatology OTC Medications Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dermatology OTC Medications Status and Outlook by Region
3.1 Global Dermatology OTC Medications Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Dermatology OTC Medications Historic Market Size by Region
3.2.1 Global Dermatology OTC Medications Sales in Volume by Region (2018-2024)
3.2.2 Global Dermatology OTC Medications Sales in Value by Region (2018-2024)
3.2.3 Global Dermatology OTC Medications Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Dermatology OTC Medications Forecasted Market Size by Region
3.3.1 Global Dermatology OTC Medications Sales in Volume by Region (2024-2034)
3.3.2 Global Dermatology OTC Medications Sales in Value by Region (2024-2034)
3.3.3 Global Dermatology OTC Medications Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Dermatology OTC Medications by Application
4.1 Dermatology OTC Medications Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 Other
4.2 Global Dermatology OTC Medications Market Size by Application
4.2.1 Global Dermatology OTC Medications Market Size Overview by Application (2018-2034)
4.2.2 Global Dermatology OTC Medications Historic Market Size Review by Application (2018-2024)
4.2.3 Global Dermatology OTC Medications Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dermatology OTC Medications Sales Breakdown by Application (2018-2024)
4.3.2 Europe Dermatology OTC Medications Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Dermatology OTC Medications Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Application (2018-2024)
5 North America Dermatology OTC Medications by Country
5.1 North America Dermatology OTC Medications Historic Market Size by Country
5.1.1 North America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Dermatology OTC Medications Sales in Volume by Country (2018-2024)
5.1.3 North America Dermatology OTC Medications Sales in Value by Country (2018-2024)
5.2 North America Dermatology OTC Medications Forecasted Market Size by Country
5.2.1 North America Dermatology OTC Medications Sales in Volume by Country (2024-2034)
5.2.2 North America Dermatology OTC Medications Sales in Value by Country (2024-2034)
6 Europe Dermatology OTC Medications by Country
6.1 Europe Dermatology OTC Medications Historic Market Size by Country
6.1.1 Europe Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Dermatology OTC Medications Sales in Volume by Country (2018-2024)
6.1.3 Europe Dermatology OTC Medications Sales in Value by Country (2018-2024)
6.2 Europe Dermatology OTC Medications Forecasted Market Size by Country
6.2.1 Europe Dermatology OTC Medications Sales in Volume by Country (2024-2034)
6.2.2 Europe Dermatology OTC Medications Sales in Value by Country (2024-2034)
7 Asia-Pacific Dermatology OTC Medications by Region
7.1 Asia-Pacific Dermatology OTC Medications Historic Market Size by Region
7.1.1 Asia-Pacific Dermatology OTC Medications Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Dermatology OTC Medications Forecasted Market Size by Region
7.2.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2024-2034)
8 Latin America Dermatology OTC Medications by Country
8.1 Latin America Dermatology OTC Medications Historic Market Size by Country
8.1.1 Latin America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Dermatology OTC Medications Sales in Volume by Country (2018-2024)
8.1.3 Latin America Dermatology OTC Medications Sales in Value by Country (2018-2024)
8.2 Latin America Dermatology OTC Medications Forecasted Market Size by Country
8.2.1 Latin America Dermatology OTC Medications Sales in Volume by Country (2024-2034)
8.2.2 Latin America Dermatology OTC Medications Sales in Value by Country (2024-2034)
9 Middle East and Africa Dermatology OTC Medications by Country
9.1 Middle East and Africa Dermatology OTC Medications Historic Market Size by Country
9.1.1 Middle East and Africa Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Dermatology OTC Medications Forecasted Market Size by Country
9.2.1 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Dermatology OTC Medications Products Offered
10.1.5 Bayer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Dermatology OTC Medications Products Offered
10.2.5 GSK Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Dermatology OTC Medications Products Offered
10.3.5 Teva Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis Dermatology OTC Medications Products Offered
10.5.5 Novartis Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Mylan Dermatology OTC Medications Products Offered
10.6.5 Mylan Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 Aurobindo
10.8.1 Aurobindo Company Information
10.8.2 Aurobindo Introduction and Business Overview
10.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Aurobindo Dermatology OTC Medications Products Offered
10.8.5 Aurobindo Recent Development
10.9 Galderma
10.9.1 Galderma Company Information
10.9.2 Galderma Introduction and Business Overview
10.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Galderma Dermatology OTC Medications Products Offered
10.9.5 Galderma Recent Development
10.10 CR SANJIU
10.10.1 CR SANJIU Company Information
10.10.2 CR SANJIU Introduction and Business Overview
10.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CR SANJIU Dermatology OTC Medications Products Offered
10.10.5 CR SANJIU Recent Development
10.11 Dr. Reddy's
10.11.1 Dr. Reddy's Company Information
10.11.2 Dr. Reddy's Introduction and Business Overview
10.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Dr. Reddy's Dermatology OTC Medications Products Offered
10.11.5 Dr. Reddy's Recent Development
10.12 Lupin
10.12.1 Lupin Company Information
10.12.2 Lupin Introduction and Business Overview
10.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Lupin Dermatology OTC Medications Products Offered
10.12.5 Lupin Recent Development
10.13 Bausch Health
10.13.1 Bausch Health Company Information
10.13.2 Bausch Health Introduction and Business Overview
10.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Bausch Health Dermatology OTC Medications Products Offered
10.13.5 Bausch Health Recent Development
10.14 Cipla
10.14.1 Cipla Company Information
10.14.2 Cipla Introduction and Business Overview
10.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Cipla Dermatology OTC Medications Products Offered
10.14.5 Cipla Recent Development
10.15 Qilu Pharmaceutical
10.15.1 Qilu Pharmaceutical Company Information
10.15.2 Qilu Pharmaceutical Introduction and Business Overview
10.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Qilu Pharmaceutical Dermatology OTC Medications Products Offered
10.15.5 Qilu Pharmaceutical Recent Development
10.16 Almirall
10.16.1 Almirall Company Information
10.16.2 Almirall Introduction and Business Overview
10.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Almirall Dermatology OTC Medications Products Offered
10.16.5 Almirall Recent Development
10.17 Lingrui
10.17.1 Lingrui Company Information
10.17.2 Lingrui Introduction and Business Overview
10.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Lingrui Dermatology OTC Medications Products Offered
10.17.5 Lingrui Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dermatology OTC Medications Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dermatology OTC Medications Industrial Chain Analysis
11.4 Dermatology OTC Medications Market Dynamics
11.4.1 Dermatology OTC Medications Industry Trends
11.4.2 Dermatology OTC Medications Market Drivers
11.4.3 Dermatology OTC Medications Market Challenges
11.4.4 Dermatology OTC Medications Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dermatology OTC Medications Distributors
12.3 Dermatology OTC Medications Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of External Use
Table 2. Major Company of Oral
Table 3. Global Dermatology OTC Medications Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Dermatology OTC Medications Sales by Type (2018-2024) & (M Units)
Table 5. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Dermatology OTC Medications Sales by Type (2018-2024) & (US& Million)
Table 7. Global Dermatology OTC Medications Market Share in Value by Type (2018-2024)
Table 8. Global Dermatology OTC Medications Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Dermatology OTC Medications Sales by Type (2024-2034) & (M Units)
Table 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Dermatology OTC Medications Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Dermatology OTC Medications Sales Market Share in Value by Type (2024-2034)
Table 13. Global Dermatology OTC Medications Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Dermatology OTC Medications Sales by Type (2018-2024) & (M Units)
Table 15. North America Dermatology OTC Medications Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Dermatology OTC Medications Sales (M Units) by Type (2018-2024)
Table 17. Europe Dermatology OTC Medications Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Dermatology OTC Medications Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Dermatology OTC Medications Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Dermatology OTC Medications Sales (M Units) by Type (2018-2024)
Table 21. Latin America Dermatology OTC Medications Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Dermatology OTC Medications Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Dermatology OTC Medications Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Dermatology OTC Medications Sales by Company (2018-2024) & (M Units)
Table 25. Global Dermatology OTC Medications Sales Share by Company (2018-2024)
Table 26. Global Dermatology OTC Medications Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Dermatology OTC Medications Revenue Share by Company (2018-2024)
Table 28. Global Market Dermatology OTC Medications Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Dermatology OTC Medications Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2022)
Table 32. Date of Key Manufacturers Enter into Dermatology OTC Medications Market
Table 33. Key Manufacturers Dermatology OTC Medications Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Dermatology OTC Medications Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Dermatology OTC Medications Sales by Region (2018-2024) & (M Units)
Table 37. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Dermatology OTC Medications Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Dermatology OTC Medications Sales Market Share in Value by Region (2018-2024)
Table 40. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Dermatology OTC Medications Sales by Region (2024-2034) & (M Units)
Table 42. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Dermatology OTC Medications Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Dermatology OTC Medications Sales Market Share in Value by Region (2024-2034)
Table 45. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Dermatology OTC Medications Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Dermatology OTC Medications Sales by Application (2018-2024) & (M Units)
Table 48. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Dermatology OTC Medications Sales Market Share in Value by Application (2018-2024)
Table 51. Global Dermatology OTC Medications Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Dermatology OTC Medications Sales by Application (2024-2034) & (M Units)
Table 53. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Dermatology OTC Medications Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Dermatology OTC Medications Sales Market Share in Value by Application (2024-2034)
Table 56. Global Dermatology OTC Medications Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Dermatology OTC Medications Sales by Application (2018-2024) (M Units)
Table 58. North America Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Dermatology OTC Medications Sales by Application (2018-2024) (M Units)
Table 60. Europe Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Dermatology OTC Medications Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Dermatology OTC Medications Sales by Application (2018-2024) (M Units)
Table 64. Latin America Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Dermatology OTC Medications Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Dermatology OTC Medications Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Dermatology OTC Medications Sales by Country (2018-2024) & (M Units)
Table 68. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Dermatology OTC Medications Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Dermatology OTC Medications Sales Market Share in Value by Country (2018-2024)
Table 71. North America Dermatology OTC Medications Sales by Country (2024-2034) & (M Units)
Table 72. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Dermatology OTC Medications Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Dermatology OTC Medications Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Dermatology OTC Medications Sales by Country (2018-2024) & (M Units)
Table 76. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Dermatology OTC Medications Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Dermatology OTC Medications Sales by Country (2024-2034) & (M Units)
Table 80. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Dermatology OTC Medications Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Dermatology OTC Medications Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Dermatology OTC Medications Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Dermatology OTC Medications Sales by Region (2024-2034) & (M Units)
Table 88. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Dermatology OTC Medications Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Dermatology OTC Medications Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Dermatology OTC Medications Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Dermatology OTC Medications Sales by Country (2024-2034) & (M Units)
Table 96. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Dermatology OTC Medications Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Dermatology OTC Medications Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Dermatology OTC Medications Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Dermatology OTC Medications Sales by Country (2024-2034) & (M Units)
Table 104. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Dermatology OTC Medications Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2024-2034)
Table 107. Bayer Company Information
Table 108. Bayer Introduction and Business Overview
Table 109. Bayer Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Dermatology OTC Medications Product
Table 111. Bayer Recent Development
Table 112. GSK Company Information
Table 113. GSK Introduction and Business Overview
Table 114. GSK Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. GSK Dermatology OTC Medications Product
Table 116. GSK Recent Development
Table 117. Teva Company Information
Table 118. Teva Introduction and Business Overview
Table 119. Teva Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Teva Dermatology OTC Medications Product
Table 121. Teva Recent Development
Table 122. Johnson & Johnson Company Information
Table 123. Johnson & Johnson Introduction and Business Overview
Table 124. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Johnson & Johnson Dermatology OTC Medications Product
Table 126. Johnson & Johnson Recent Development
Table 127. Novartis Company Information
Table 128. Novartis Introduction and Business Overview
Table 129. Novartis Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Dermatology OTC Medications Product
Table 131. Novartis Recent Development
Table 132. Mylan Company Information
Table 133. Mylan Introduction and Business Overview
Table 134. Mylan Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Mylan Dermatology OTC Medications Product
Table 136. Mylan Recent Development
Table 137. Sun Pharmaceutical Company Information
Table 138. Sun Pharmaceutical Introduction and Business Overview
Table 139. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Sun Pharmaceutical Dermatology OTC Medications Product
Table 141. Sun Pharmaceutical Recent Development
Table 142. Aurobindo Company Information
Table 143. Aurobindo Introduction and Business Overview
Table 144. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Aurobindo Dermatology OTC Medications Product
Table 146. Aurobindo Recent Development
Table 147. Galderma Company Information
Table 148. Galderma Introduction and Business Overview
Table 149. Galderma Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Galderma Dermatology OTC Medications Product
Table 151. Galderma Recent Development
Table 152. CR SANJIU Company Information
Table 153. CR SANJIU Introduction and Business Overview
Table 154. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. CR SANJIU Dermatology OTC Medications Product
Table 156. CR SANJIU Recent Development
Table 157. Dr. Reddy's Company Information
Table 158. Dr. Reddy's Introduction and Business Overview
Table 159. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Dr. Reddy's Dermatology OTC Medications Product
Table 161. Dr. Reddy's Recent Development
Table 162. Lupin Company Information
Table 163. Lupin Introduction and Business Overview
Table 164. Lupin Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Lupin Dermatology OTC Medications Product
Table 166. Lupin Recent Development
Table 167. Bausch Health Company Information
Table 168. Bausch Health Introduction and Business Overview
Table 169. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Bausch Health Dermatology OTC Medications Product
Table 171. Bausch Health Recent Development
Table 172. Cipla Company Information
Table 173. Cipla Introduction and Business Overview
Table 174. Cipla Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Cipla Dermatology OTC Medications Product
Table 176. Cipla Recent Development
Table 177. Qilu Pharmaceutical Company Information
Table 178. Qilu Pharmaceutical Introduction and Business Overview
Table 179. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Qilu Pharmaceutical Dermatology OTC Medications Product
Table 181. Qilu Pharmaceutical Recent Development
Table 182. Almirall Company Information
Table 183. Almirall Introduction and Business Overview
Table 184. Almirall Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Almirall Dermatology OTC Medications Product
Table 186. Almirall Recent Development
Table 187. Lingrui Company Information
Table 188. Lingrui Introduction and Business Overview
Table 189. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Lingrui Dermatology OTC Medications Product
Table 191. Lingrui Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Dermatology OTC Medications Market Trends
Table 195. Dermatology OTC Medications Market Drivers
Table 196. Dermatology OTC Medications Market Challenges
Table 197. Dermatology OTC Medications Market Restraints
Table 198. Dermatology OTC Medications Distributors List
Table 199. Dermatology OTC Medications Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology OTC Medications Product Picture
Figure 2. Global Dermatology OTC Medications Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Dermatology OTC Medications Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Dermatology OTC Medications Sales Status and Outlook (2018-2034) & (M Units)
Figure 5. Product Picture of External Use
Figure 6. Global External Use Sales YoY Growth (2018-2034) & (M Units)
Figure 7. Product Picture of Oral
Figure 8. Global Oral Sales YoY Growth (2018-2034) & (M Units)
Figure 9. Global Dermatology OTC Medications Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Dermatology OTC Medications Sales Market Share by Type in 2022 & 2034
Figure 11. North America Dermatology OTC Medications Sales Market Share in Volume by Type in 2022
Figure 12. North America Dermatology OTC Medications Sales Market Share in Value by Type in 2022
Figure 13. Europe Dermatology OTC Medications Sales Market Share in Volume by Type in 2022
Figure 14. Europe Dermatology OTC Medications Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Type in 2022
Figure 17. Latin America Dermatology OTC Medications Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Dermatology OTC Medications Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Revenue in 2022
Figure 23. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (M Units)
Figure 26. Product Picture of Drug Store
Figure 27. Global Drug Store Sales YoY Growth (2018-2034) & (M Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (M Units)
Figure 30. Global Dermatology OTC Medications Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Dermatology OTC Medications Sales Market Share by Application in 2022 & 2034
Figure 32. North America Dermatology OTC Medications Sales Market Share in Volume by Application in 2022
Figure 33. North America Dermatology OTC Medications Sales Market Share in Value by Application in 2022
Figure 34. Europe Dermatology OTC Medications Sales Market Share in Volume by Application in 2022
Figure 35. Europe Dermatology OTC Medications Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Application in 2022
Figure 38. Latin America Dermatology OTC Medications Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Dermatology OTC Medications Manufacturing Cost Structure
Figure 43. Dermatology OTC Medications Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries